Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

CD39 inhibitor

DRUG CLASS:

CD39 inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

HOXA9 overexpression + MEIS1 overexpression

Acute Myelogenous Leukemia

Sensitive: D – Preclinical

Sensitive: D – Preclinical